Other mechanisms able to deregulate KRAS gene in ovarian cancer are gene amplifications that account in about 11% of ovarian tumors [53] and short RNA molecule (miRNA) let-7 [54]. This evidence concerns the gene KRAS and ovarian carcinoma.